Gapping down
In reaction to disappointing earnings/guidance: FLO -17.1%, LPSN-16.7%, MYL -12.5%, IFF -12.2%, PPC -10.9%, BTU -10.7%, ZNGA -10.3%,IRBT -9%, TWTR -6.9%, DBD -6.9%, TTM -6.7%, LOCK -6.6%, RAVE-6.5%, PLAB -5.9%, OII -5.6%, AVP -4.6%, KKR -4.3%, TEVA -4.3%, HNI-3.8%, CSOD -3.6%, PXD -2.6%, (also reports YE 2015 reserves and finding costs; add proved reserves totaling 210 MMBOE during 2015 from discoveries, extensions and technical revisions of previous estimates),CXW -2.6%, TOT -2.4%, TOT -2.4%, BG -2.3%, TAP -2.1%, WFM -2%, VII-1.8%, O -1.4%, CYS -1.3%, CAMT -1.1%
Select financial related names showing weakness: DB -6.7%, BCS -6.1%,HSBC -3.9%, SAN -3.8%, ING -3.2%, BAC -3.2%, MS -3.1%
Select oil/gas related names showing early weakness: WLL -5.4%, APC-4.5%, RIG -3.6%, BP -3.5%, MRO -2.5%
Other news: INCY -15.4% (to discontinue Phase 3 study (JANUS 1) of ruxolitinib in combination with capecitabine; also reported earnings),MYL -12.5% (Mylan Labs confirms plans to acquire Meda (MDABY) for SEK 165 per Meda Share; expected to be immediately accretive ), AMPE-5.2% ( enters into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald to implement an 'at-the-market' equity offering program to offer and sell up to $25 mln in shares of its common stock),SUNE -5.1% (trading lower with mkt), BHP -3.9% (in symp with RIO earnings), MHGC -3.5% (provides corporate update; believes that it has sufficient liquidity to meet its current working capital needs), CLR -1.8% (announced YE 2015 proved reserves of 1.23 bln Boe, -9% YoY),
Analyst comments: SCTY -1.8% (downgraded to Equal Weight from Overweight at Barclays)
In reaction to disappointing earnings/guidance: FLO -17.1%, LPSN-16.7%, MYL -12.5%, IFF -12.2%, PPC -10.9%, BTU -10.7%, ZNGA -10.3%,IRBT -9%, TWTR -6.9%, DBD -6.9%, TTM -6.7%, LOCK -6.6%, RAVE-6.5%, PLAB -5.9%, OII -5.6%, AVP -4.6%, KKR -4.3%, TEVA -4.3%, HNI-3.8%, CSOD -3.6%, PXD -2.6%, (also reports YE 2015 reserves and finding costs; add proved reserves totaling 210 MMBOE during 2015 from discoveries, extensions and technical revisions of previous estimates),CXW -2.6%, TOT -2.4%, TOT -2.4%, BG -2.3%, TAP -2.1%, WFM -2%, VII-1.8%, O -1.4%, CYS -1.3%, CAMT -1.1%
Select financial related names showing weakness: DB -6.7%, BCS -6.1%,HSBC -3.9%, SAN -3.8%, ING -3.2%, BAC -3.2%, MS -3.1%
Select oil/gas related names showing early weakness: WLL -5.4%, APC-4.5%, RIG -3.6%, BP -3.5%, MRO -2.5%
Other news: INCY -15.4% (to discontinue Phase 3 study (JANUS 1) of ruxolitinib in combination with capecitabine; also reported earnings),MYL -12.5% (Mylan Labs confirms plans to acquire Meda (MDABY) for SEK 165 per Meda Share; expected to be immediately accretive ), AMPE-5.2% ( enters into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald to implement an 'at-the-market' equity offering program to offer and sell up to $25 mln in shares of its common stock),SUNE -5.1% (trading lower with mkt), BHP -3.9% (in symp with RIO earnings), MHGC -3.5% (provides corporate update; believes that it has sufficient liquidity to meet its current working capital needs), CLR -1.8% (announced YE 2015 proved reserves of 1.23 bln Boe, -9% YoY),
Analyst comments: SCTY -1.8% (downgraded to Equal Weight from Overweight at Barclays)